Colgate-Palmolive director sells 4,170 shares

The option became exercisable in one-third increments beginning on the first anniversary of its May 13, 2019 grant date.

Available on EDGAR 11/09/2026 - 04:04 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Colgate-Palmolive (CL) director Lorrie M. Norrington exercised options covering 4,170 shares on November 5, 2026, at an exercise price of $71.56 per share, acquired 4,170 common shares and sold 4,170 shares at $99.3101 per share. A portion of the sale proceeds was delivered to Colgate-Palmolive to pay the option exercise price. The reported balance for the exercised options after the transaction was 0 shares.

Insider Trade Summary

Exercise and Sale: 4,170 shares ($116K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider NORRINGTON LORRIE M

Role Director

Sold 4,170 shs ($414K)

Approx. gross sale proceeds $414K

Approx. exercise cost $298K

Approx. pre-tax spread $116K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1, F3	4,170	$0.00	$0.00
Exercise	Common Stock F1	4,170	$71.56	$298K
Sale	Common Stock F2	4,170	$99.3101	$414K

Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Common Stock — 43,383 shares (Direct)

Footnotes (3)

1. F1. Exercise of stock options awarded under the issuer's incentive compensation plan.
2. F2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
3. F3. Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2019 grant date.

Key Figures

Options exercised: 4,170 shares Exercise price: $71.56 per share Shares sold: 4,170 shares +2 more

5 metrics

Options exercised 4,170 shares November 5, 2026

Exercise price $71.56 per share Options exercised November 5, 2026

Shares sold 4,170 shares November 5, 2026

Sale price $99.3101 per share November 5, 2026

Reported balance for exercised options 0 shares Following the November 5, 2026 transaction

Key Terms

stock options, incentive compensation plan, exercise price

3 terms

stock options financial

"Exercise of stock options awarded"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

incentive compensation plan financial

"under the issuer's incentive compensation plan"

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

exercise price financial

"for payment of the exercise price of options"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CL shares did Lorrie M. Norrington sell?

Lorrie M. Norrington, a director, sold 4,170 Colgate-Palmolive common shares on November 5, 2026, at $99.3101 per share after exercising options covering 4,170 shares at $71.56 per share. A portion of the sale proceeds was delivered to Colgate-Palmolive for payment of the exercise price; no Rule 10b5-1 plan is reported.

When did Lorrie M. Norrington's options become exercisable?

The options became exercisable in one-third increments beginning on the first anniversary of the May 13, 2019 grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NORRINGTON LORRIE M

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/05/2026		M(1)		4,170	A	$71.56	47,553	D
Common Stock	11/05/2026		S(2)		4,170	D	$99.3101	43,383	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$71.56	11/05/2026		M(1)			4,170	(3)	05/13/2027	Common Stock	4,170	$0.0000	0.0000	D

Explanation of Responses:

1. Exercise of stock options awarded under the issuer's incentive compensation plan.

2. Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.

3. Option became exercisable in one-third increments beginning on the first anniversary of the May 13, 2019 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)